Pharmaceutical industry – Page 50
-
-
Business
Endo Health to buy Boca Pharmacal for $225m
Endo agrees to buy generics firm Boca as two major patents expire
-
Business
Nice rules against Afinitor
Novartis’ drug will not routinely be available on the UK health service
-
Business
Couple charged in GSK corruption investigation
Two private investigators have been charged with breaching the privacy rights of Chinese citizens
-
Business
J&J buys Aragon’s prostate cancer arm
Hormone cancer specialist spins out other programmes before sale
-
Business
Two way traffic for Chinese drug licensing
Western companies are seeing more value in Chinese innovation
-
Business
Boehringer to close manufacturing plants and cut jobs
Two US plants and a total of 640 jobs to go by the end of next year
-
News
Chinese drug watchdog set for major reforms
Measures will speed up drug approvals and decentralise controls on generics
-
News
Indian U-turn on diabetes drug ban
Suspension of cheap and popular medicine reversed but will now come with new safety warnings
-
Business
Antiviral patents released by Roche
Firm will supply cheap drugs and allow generics in developing countries
-
News
Execution drug cannot be imported into US
Court rules that the Food and Drug Administration acted unlawfully allowing sodium thiopental into the country
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
Business
Pfizer reshuffle hints at future split decision
Could pharma giant’s ‘value’ and ‘innovative’ segments get broken apart?
-
Business
Perrigo bags Elan and its bargain Irish tax rates
$8.6bn deal ends Elan’s takeover battle with Royalty Pharma
-
Business
Thousands face job cuts after Valeant's Bausch buyout
Valeant plans to shed 10-15% of its workforce to save $800 million
-
Business
China corruption investigation broadens
GSK scandal is the trigger to clean up Chinese drug market
-
Business
Lilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business
GSK under investigation over corruption in China
Police claim executives engaged in bribery and tax-related crimes
-
Business
Evotec moves business back to UK
Pharma company closes operations in India, citing distance from customers
-
Business
Biosimilar drugs step up complexity
First generic monoclonal antibodies recommended for approval in Europe